Note 13 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Sales, net	$ 56,246	$ 63,559
Gross Profit	6,552	9,480
Depreciation	336	337
Capital Expenditures	486	295
Contract Manufacturing	25,250	25,440
Contract Manufacturing [Member]
Sales, net	54,091	61,835
Gross Profit	5,917	9,020
Depreciation	332	332
Capital Expenditures	486	292
Contract Manufacturing	19,061	21,333
Other Nutraceutical Business [Member]
Sales, net	2,155	1,724
Gross Profit	635	460
Depreciation	4	5
Capital Expenditures	0	3
Contract Manufacturing	6,189	4,107
UNITED STATES
Sales, net	46,517	54,387
UNITED STATES | Contract Manufacturing [Member]
Sales, net	44,450	52,763
UNITED STATES | Other Nutraceutical Business [Member]
Sales, net	2,067	1,624
Non-US [Member]
Sales, net	9,729	9,172
Non-US [Member] | Contract Manufacturing [Member]
Sales, net	9,641	9,072
Non-US [Member] | Other Nutraceutical Business [Member]
Sales, net	$ 88	$ 100